 09 Jun 2020 - Immutep Limited ASX:IMM Executive Director and CEO Marc Voigt, Chief Scientific and Medical Officer Dr Frédéric Triebel, and Director Clinical Development and Regulatory Affairs Christian Mueller present on Immuteps latest clinical results. 